No Data
Ningbo Sanxing Medical Electric (601567.SH): Subsidiary is expected to win the bidding for the 0.314 billion yuan Southern Power Grid bidding project.
On January 22, Gelonghui reported that Ningbo Sanxing Medical Electric (601567.SH) announced that its subsidiary, Ningbo AUX Intelligent Technology Co., Ltd. (referred to as "AUX Intelligent Technology"), was recently recommended as a candidate for the bid in the second batch of framework bidding projects for distribution network equipment by Southern Power Grid Company for 2024, with an expected winning bid amount of approximately 313.8232 million yuan. According to the public notice, the company is responsible for this project’s 10kV oil-immersed transformers (excluding amorphous alloy types), 10kV amorphous alloy oil-immersed distribution transformers, 10kV SCB dry-type transformers, and 10kV pre-assembled substations (European style, compact).
China International Capital Corporation: State Grid's investment exceeds 650 billion yuan for the first time, with continued upward momentum.
It is expected that in 2025, Ultra High Pressure is likely to approve "Four Direct and Four Alternating," with investments in Ultra High Pressure anticipated to grow by approximately 30% year-on-year.
Overview of the lifting of restrictions on A-shares by Zhitong | January 13.
According to Zhito Finance APP, on January 13, a total of 14 listed companies had their restricted stocks released, with a total market value of approximately 9.316 billion yuan. The specific status of the restricted stock release today is as follows: Stock Abbreviation Stock Code Type of Restricted Stock Number of Released Stocks Tai Mushi 001234 Pre-issue Shares Restricted Circulation 77.6 million Shanghai Bairun Investment Holding Group 002568 Stock-based Incentive Restricted Circulation 1.0696 million Ningbo Sanxing Medical Electric 601567 Stock-based Incentive Restricted Circulation 3.8059 million Ningbo Peacebird Fashion 603877 Stock-based Incentive Restricted Circulation 1.149 million Zhejiang Tiantai Xianghe Industrial 603500 Stock-based Incentive Restricted Circulation 1.138 million Haofan Biology 3
Ningbo Sanxing Medical Electric Co.,Ltd.'s (SHSE:601567) Intrinsic Value Is Potentially 87% Above Its Share Price
Ningbo Sanxing Medical Electric (601567.SH): In 2024, it has won the bid for the 0.836 billion wind power and photovoltaic prefabricated substation project of Datang Group, and the 0.176 billion box transformer equipment project of China General Nuclear P
On January 7, Gelonghui reported that Ningbo Sanxing Medical Electric (601567.SH) disclosed the record of investor relations activities, indicating that domestically, the company is leveraging its advantages in the power grid Business and focusing on the New energy Fund sector to enhance the coverage of five major and six minor power generation central enterprises, deeply exploring the bidding demands of provincial companies and increasing the development of major clients in local state-owned assets and other Industries. In 2024, the company has won the bid for the 0.836 billion wind power photovoltaic prefabricated substation project from Datang Group and the 0.176 billion box transformer equipment project from China General Nuclear Power Corporation.
Ningbo Sanxing Medical Electric (601567.SH): The overseas sales network has covered more than 70 countries and regions globally.
On January 7, Gelonghui reported that Ningbo Sanxing Medical Electric (601567.SH) disclosed the investor relationship activity record form, indicating that the company is continuously improving its global marketing network system and deepening local Operation. The overseas sales network has covered more than 70 countries and regions globally, with key overseas clients including Sweden's Vattenfall, Europe's E.on Group, Brazil's Enel Electrical Utilities, and Saudi SEC Electrical Utilities. The company focuses on the high-end market, continuously delving into Europe and the Middle East, with Europe covering 16 countries, making it the Chinese company with the most extensive presence in the European Industry. At the same time, the company has already
Investors in Ningbo Sanxing Medical ElectricLtd (SHSE:601567) Have Seen Enviable Returns of 345% Over the Past Three Years
